Live Chat

Berdagang Gilead GILD

Gilead carta live

Wawasan

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Berita

Maklumat

Sebaran nilai

0.52

Spread (%)

0.6156 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Jumaat

13:31 - 19:59

Isnin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Khamis

13:31-19:59

Penyata Pendapatan

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

107243429888

Saham Tertunggak

1244989952

Tarikh Pendapatan (Seterusnya)

2013-01-28

Hasil Div

2024-09-27

Tarikh Selepas Dividen

2024-09-13

Kadar dividen tahunan depan

3.08

Hasil dividen tahunan depan

0.0358

EPS

0.82

Saham Tertunggak

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Ketahui lebih lanjut mengenai instrumen ini

Instrumen Berkaitan

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

Wall Street's leading indices notch fresh records ahead of US inflation data release later today

Khamis, 10 Oktober 2024

Wall St. soars to new highs ahead of US inflation report

Rabu, 9 Oktober 2024

Hang Seng index surges, breaking 21,000 mark

Rabu, 9 Oktober 2024

Dow Jones index today: Dow Hit Record Closing Highs

Rabu, 9 Oktober 2024

Nvidia stock surges 4% in Tuesday, notching its fifth straight day of gains

Live Chat